These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20637319)

  • 1. DNA binding domain of RFX5: interactions with X-box DNA and RFXANK.
    Chakraborty M; Sengupta A; Bhattacharya D; Banerjee S; Chakrabarti A
    Biochim Biophys Acta; 2010 Oct; 1804(10):2016-24. PubMed ID: 20637319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
    Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
    Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins.
    Burd AL; Ingraham RH; Goldrick SE; Kroe RR; Crute JJ; Grygon CA
    Biochemistry; 2004 Oct; 43(40):12750-60. PubMed ID: 15461447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y.
    Villard J; Peretti M; Masternak K; Barras E; Caretti G; Mantovani R; Reith W
    Mol Cell Biol; 2000 May; 20(10):3364-76. PubMed ID: 10779326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
    Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the RFX complex and the RFX5(L66A) mutant: implications for the regulation of MHC class II gene expression.
    Garvie CW; Stagno JR; Reid S; Singh A; Harrington E; Boss JM
    Biochemistry; 2007 Feb; 46(6):1597-611. PubMed ID: 17279624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and conformational studies on dityrosine formation in the DNA binding domain of RFX5.
    Chakraborty M; Bhattacharya D; Mukhopadhyay C; Chakrabarti A
    Biophys Chem; 2010 Jul; 149(3):92-101. PubMed ID: 20457484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers.
    Jabrane-Ferrat N; Nekrep N; Tosi G; Esserman LJ; Peterlin BM
    Mol Cell Biol; 2002 Aug; 22(15):5616-25. PubMed ID: 12101253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assembly of the RFX complex on the MHCII promoter: role of RFXAP and RFXB in relieving autoinhibition of RFX5.
    Garvie CW; Boss JM
    Biochim Biophys Acta; 2008 Dec; 1779(12):797-804. PubMed ID: 18723135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
    Krawczyk M; Masternak K; Zufferey M; Barras E; Reith W
    Mol Cell Biol; 2005 Oct; 25(19):8607-18. PubMed ID: 16166641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orientation and positional mapping of the subunits of the multicomponent transcription factors RFX and X2BP to the major histocompatibility complex class II transcriptional enhancer.
    Westerheide SD; Boss JM
    Nucleic Acids Res; 1999 Apr; 27(7):1635-41. PubMed ID: 10075994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of the heterotrimeric complex between the interaction domains of RFX5 and RFXAP from the RFX gene regulatory complex.
    Laird KM; Briggs LL; Boss JM; Summers MF; Garvie CW
    J Mol Biol; 2010 Oct; 403(1):40-51. PubMed ID: 20732328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex.
    Nekrep N; Jabrane-Ferrat N; Peterlin BM
    Mol Cell Biol; 2000 Jun; 20(12):4455-61. PubMed ID: 10825209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.
    Durand B; Sperisen P; Emery P; Barras E; Zufferey M; Mach B; Reith W
    EMBO J; 1997 Mar; 16(5):1045-55. PubMed ID: 9118943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hierarchy of nuclear localization signals governs the import of the regulatory factor X complex subunits and MHC class II expression.
    Nagarajan UM; Long AB; Harreman MT; Corbett AH; Boss JM
    J Immunol; 2004 Jul; 173(1):410-9. PubMed ID: 15210800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency.
    Matheux F; Ikinciogullari A; Zapata DA; Barras E; Zufferey M; Dogu F; Regueiro JR; Reith W; Villard J
    Mol Ther; 2002 Dec; 6(6):824-9. PubMed ID: 12498778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of the RFX gene regulatory complex induces folding of the interaction domain of RFXAP.
    Briggs L; Laird K; Boss JM; Garvie CW
    Proteins; 2009 Aug; 76(3):655-64. PubMed ID: 19274739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of the Bare lymphocyte syndrome.
    Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Reith W
    Rev Immunogenet; 2000; 2(2):267-82. PubMed ID: 11258423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes.
    Louis-Plence P; Moreno CS; Boss JM
    J Immunol; 1997 Oct; 159(8):3899-909. PubMed ID: 9378978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class I and II deficiencies.
    Hanna S; Etzioni A
    J Allergy Clin Immunol; 2014 Aug; 134(2):269-75. PubMed ID: 25001848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.